New Alzheimer’s Treatment Shows Promise in Animal Tests

What's Hot


The Most Sinful City in the U.S. Is … (Hint: It’s Not Vegas)Family

How a Mexican Tariff Will Boost the Cost of 6 Common PurchasesFamily

This Free Software Brings Old Laptops Back to LifeMore

How to Protect Yourself From the ‘Can You Hear Me?’ Phone ScamFamily

Report: Walmart to Begin Selling CarsCars

Is Your TV Tracking You? Here’s How to Tell — and Prevent ItAround The House

Trump Scraps FHA Rate Cut — What Does It Mean for You?Borrow

Where to Sell Your Stuff for Top DollarAround The House

11 Staging Tips to Help You Get Top Dollar When Selling Your HomeAround The House

8 Tuition-Free U.S. CollegesCollege

10 Overlooked Expenses That Ruin Your BudgetFamily

4 Car Insurers That Might Raise Rates Even When the Accident Wasn’t Your FaultCars

How to Invest If Trump Kills the ‘Fiduciary Rule’Grow

20 Simple Hacks to Make Your Stuff Last LongerAround The House

12 Surprising Ways to Wreck Your Credit ScoreBorrow

Nitroglycerin combined with an Alzheimer's drug has been shown to reverse brain damage caused by the disease in mice. It's still a long way from being tested on people.

A team of scientists has discovered a drug that, in mice, seems to stop and partially reverse damage done by Alzheimer’s disease.

Their research was just published in the Proceedings of the National Academy of Sciences following a 10-year study, the Orlando Sentinel says.

The scientists at the Sanford-Burnham Medical Research Institute tried 37 combinations of two existing drugs, nitroglycerin and memantine, before finding one that seemed to have an impact.

Nitroglycerin is used to treat chest pain, while memantine is already used to treat Alzheimer’s but isn’t very effective on its own, the paper says. The combination of the two is known as NitroMemantine.

“In [mice] models, the hybrid appears to restore synapses — the connections between neurons — lost in the disease process,” the Orlando Sentinel says. It begins to work within a few hours and can restore synapses within a few months. The research team believes it is the first drug to do so.

Other scientists agree the research is promising, the paper notes, but it will be several years before trials are conducted on humans.

Alzheimer’s afflicts an estimated 5.2 million people in the U.S., the Alzheimer’s Association says, with a direct national cost of $203 billion a year. About $34 billion of that is out-of-pocket expense.

You can look at the research study here for $10, but it uses phrases like “extrasynaptic NMDA receptors” and “miniature excitatory postsynaptic currents.”

Stacy Johnson

It's not the usual blah, blah, blah

I know... every site you visit wants you to subscribe to their newsletter. But our news and advice is actually worth reading! For 25 years, I've been making people richer without making their eyes glaze over. You'll be glad you did. I guarantee it!

💰🗣📰

Read Next: 21 Restaurants Offering Free Food Right Now

Check Out Our Hottest Deals!

We're always adding new deals and coupons that'll save you big bucks. See the deals to the right and hundreds more in our Deals section.

Click here to explore 1,865 more deals!